Clinical Trial Update: Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation [Phase 2]

View source ↗

Summary

Phase II randomized, placebo-controlled study of ATI-7505 in chronic constipation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• ATI 7505

Snippet

Sponsor: Procter and Gamble | Conditions: Chronic Constipation | Phase 2 | Status: TERMINATED